KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Dividends Paid - Preferred (2018 - 2021)

Arbutus Biopharma (ABUS) has disclosed Dividends Paid - Preferred for 4 consecutive years, with $574000.0 as the latest value for Q4 2021.

  • Quarterly Dividends Paid - Preferred fell 81.62% to $574000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $574000.0 through Sep 2022, down 96.09% year-over-year, with the annual reading at $12.1 million for FY2021, 0.13% changed from the prior year.
  • Dividends Paid - Preferred hit $574000.0 in Q4 2021 for Arbutus Biopharma, down from $5.1 million in the prior quarter.
  • In the past five years, Dividends Paid - Preferred ranged from a high of $5.7 million in Q4 2019 to a low of $574000.0 in Q4 2021.
  • Historically, Dividends Paid - Preferred has averaged $3.0 million across 4 years, with a median of $2.9 million in 2019.
  • Biggest five-year swings in Dividends Paid - Preferred: soared 114.28% in 2019 and later tumbled 81.62% in 2021.
  • Year by year, Dividends Paid - Preferred stood at $2.6 million in 2018, then soared by 114.28% to $5.7 million in 2019, then tumbled by 44.94% to $3.1 million in 2020, then tumbled by 81.62% to $574000.0 in 2021.
  • Business Quant data shows Dividends Paid - Preferred for ABUS at $574000.0 in Q4 2021, $5.1 million in Q3 2021, and $3.3 million in Q2 2021.